Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma ; volume:12 ; number:1 ; day:9 ; month:4 ; year:2024 ; pages:1-19 ; date:12.2024
Cancer & metabolism ; 12, Heft 1 (9.4.2024), 1-19, 12.2024

Classification
Medizin, Gesundheit

Creator
Peterson, Erik R.
Sajjakulnukit, Peter
Scott, Andrew J.
Heaslip, Caleb
Andren, Anthony
Wilder-Romans, Kari
Zhou, Weihua
Palavalasa, Sravya
Korimerla, Navyateja
Lin, Angelica
O’Brien, Alexandra
Kothari, Ayesha
Zhao, Zitong
Zhang, Li
Morgan, Meredith A.
Venneti, Sriram
Koschmann, Carl
Jabado, Nada
Lyssiotis, Costas A.
Castro, Maria G.
Wahl, Daniel R.
Contributor
SpringerLink (Online service)

DOI
10.1186/s40170-024-00341-7
URN
urn:nbn:de:101:1-2406241138554.494343295395
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:48 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Peterson, Erik R.
  • Sajjakulnukit, Peter
  • Scott, Andrew J.
  • Heaslip, Caleb
  • Andren, Anthony
  • Wilder-Romans, Kari
  • Zhou, Weihua
  • Palavalasa, Sravya
  • Korimerla, Navyateja
  • Lin, Angelica
  • O’Brien, Alexandra
  • Kothari, Ayesha
  • Zhao, Zitong
  • Zhang, Li
  • Morgan, Meredith A.
  • Venneti, Sriram
  • Koschmann, Carl
  • Jabado, Nada
  • Lyssiotis, Costas A.
  • Castro, Maria G.
  • Wahl, Daniel R.
  • SpringerLink (Online service)

Other Objects (12)

Prognostic factors analysis of diffuse midline glioma

Prognostic factors analysis of diffuse midline glioma

Correction to: Prognostic factors analysis of diffuse midline glioma

Correction to: Prognostic factors analysis of diffuse midline glioma

Specific Combination Therapy for H3K27M Pediatric Diffuse Midline Glioma

Specific Combination Therapy for H3K27M Pediatric Diffuse Midline Glioma

A H3K27M-targeted vaccine in adults with diffuse midline glioma

A H3K27M-targeted vaccine in adults with diffuse midline glioma

MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered

MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered

Infusion-related side-effects during convection enhanced delivery for brainstem-diffuse midline glioma/diffuse intrinsic pontine glioma

Infusion-related side-effects during convection enhanced delivery for brainstem-diffuse midline glioma/diffuse intrinsic pontine glioma

Flank Pain as a First Symptom of a Diffuse Midline Glioma

Flank Pain as a First Symptom of a Diffuse Midline Glioma

A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis

A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis

Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant

Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant

Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma

Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma

Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline glioma

Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline glioma

Single-cell RNA sequencing of anaplastic ependymoma and H3K27M-mutant diffuse midline glioma

Single-cell RNA sequencing of anaplastic ependymoma and H3K27M-mutant diffuse midline glioma

Related objects